| 000 | 01735 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516162802.0 | ||
| 264 | 0 | _c20131119 | |
| 008 | 201311s 0 0 eng d | ||
| 022 | _a1479-683X | ||
| 024 | 7 |
_a10.1530/EJE-13-0493 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWierckx, K | |
| 245 | 0 | 0 |
_aPrevalence of cardiovascular disease and cancer during cross-sex hormone therapy in a large cohort of trans persons: a case-control study. _h[electronic resource] |
| 260 |
_bEuropean journal of endocrinology _cOct 2013 |
||
| 300 |
_a471-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xepidemiology |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCerebrovascular Disorders _xepidemiology |
| 650 | 0 | 4 | _aCross-Sectional Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 |
_aGonadal Steroid Hormones _xtherapeutic use |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMorbidity |
| 650 | 0 | 4 |
_aMyocardial Infarction _xepidemiology |
| 650 | 0 | 4 |
_aNeoplasms _xepidemiology |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aPulmonary Embolism _xepidemiology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTransgender Persons _xstatistics & numerical data |
| 650 | 0 | 4 |
_aVenous Thrombosis _xepidemiology |
| 700 | 1 | _aElaut, E | |
| 700 | 1 | _aDeclercq, E | |
| 700 | 1 | _aHeylens, G | |
| 700 | 1 | _aDe Cuypere, G | |
| 700 | 1 | _aTaes, Y | |
| 700 | 1 | _aKaufman, J M | |
| 700 | 1 | _aT'Sjoen, G | |
| 773 | 0 |
_tEuropean journal of endocrinology _gvol. 169 _gno. 4 _gp. 471-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/EJE-13-0493 _zAvailable from publisher's website |
| 999 |
_c22964947 _d22964947 |
||